The double immunohistochemistry revealed that, in control tumors developed in IL-30KO and, especially, in IL-30−/−tumors, the caspase-3+ cancer cells were in close contact with, and frequently embraced by, CD3+T lymphocytes (Fig. 3B), thus suggesting their cytotoxic effector function. Here, CASP3 is linked to cancer.